Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer

Molecular Cancer

Volumn 13, Issue 1, 2014, Pages

  Singh, Ramesh ^a   Pochampally, Radhika ^a   Watabe, Kounosuke ^b   Lu, Zhaohui ^c   Mo, Yin Yuan ^b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Exosome; Invasion; microRNA; miR 10b

Indexed keywords

CERAMIDE; KRUPPEL LIKE FACTOR 4; MICRORNA 10B; HOMEODOMAIN PROTEIN; HOXD10 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; MICRORNA; MIRN10 MICRORNA, HUMAN; TRANSCRIPTION FACTOR;

ARTICLE; BREAST CANCER; BREAST METASTASIS; CELL INVASION; CELL INVASION ASSAY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EXOSOME; GENE; HOXD10 GENE; HUMAN; HUMAN CELL; KLF4 GENE; LUCIFERASE ASSAY; PROTEIN EXPRESSION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; TUMOR MICROENVIRONMENT; WESTERN BLOTTING; BREAST TUMOR; CELL MOTION; FEMALE; GENETICS; TUMOR CELL LINE; TUMOR INVASION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; EXOSOMES; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICRORNAS; NEOPLASM INVASIVENESS; TRANSCRIPTION FACTORS;

EID: 84934939517     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-13-256     Document Type: Article

References (37)

1. Lee TH, D'Asti E, Magnus N, Al-Nedawi K, Meehan B, Rak J: Microvesicles as mediators of intercellular communication in cancer-the emerging science of cellular 'debris'. Semin Immunopathol 1, 33:455-467. 10.1007/s00281-011-0250-3
2. Zomer A, Vendrig T, Hopmans ES, van Eijndhoven M, Middeldorp JM, Pegtel DM: Exosomes: Fit to deliver small RNA. Commun Integr Biol 1, 3:447-450. 10.4161/cib.3.5.12339
3. Simons M, Raposo G: Exosomes-vesicular carriers for intercellular communication. Curr Opin Cell Biol 1, 21:575-581. 10.1016/j.ceb.2009.03.007
4. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO: Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 1, 9:654-659. 10.1038/ncb1596
5. Wang K, Zhang S, Weber J, Baxter D, Galas DJ: Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res 1, 38:7248-7259. 10.1093/nar/gkq601
6. Ohshima K, Inoue K, Fujiwara A, Hatakeyama K, Kanto K, Watanabe Y, Muramatsu K, Fukuda Y, Ogura S, Yamaguchi K, Mochizuki T: Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One 1, 5:e13247. 10.1371/journal.pone.0013247
7. Kosaka N, Iguchi H, Ochiya T: Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 1, 101:2087-2092. 10.1111/j.1349-7006.2010.01650.x
8. Mar-Aguilar F, Mendoza-Ramirez JA, Malagon-Santiago I, Espino-Silva PK, Santuario-Facio SK, Ruiz-Flores P, Rodriguez-Padilla C, Resendez-Perez D: Serum circulating microRNA profiling for identification of potential breast cancer biomarkers. Dis Markers 1, 34:163-169. 10.1155/2013/259454
9. Anfossi S, Giordano A, Gao H, Cohen EN, Tin S, Wu Q, Garza RJ, Debeb BG, Alvarez RH, Valero V, Hortobagyi GN, Calin GA, Ueno NT, Woodward WA, Reuben JM: High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+inflammatory breast cancer. PLoS One 2014,9(1):e83113. doi: 10.1371/journal.pone.0083113 10.1371/journal.pone.0083113
10. Roth C, Rack B, Muller V, Janni W, Pantel K, Schwarzenbach H: Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res 1, 12:R90. 10.1186/bcr2766
11. Zhou W, Fong MY, Min Y, Somlo G, Liu L, Palomares MR, Yu Y, Chow A, O'Connor ST, Chin AR, Yen Y, Wang Y, Marcusson EG, Chu P, Wu J, Wu X, Li AX, Li Z, Gao H, Ren X, Boldin MP, Lin PC, Wang SE: Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell 2014,25(4):501-515. doi: 10.1016/j.ccr.2014.03.007 10.1016/j.ccr.2014.03.007
12. Kosaka N, Iguchi H, Hagiwara K, Yoshioka Y, Takeshita F, Ochiya T: Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis. J Biol Chem 1, 288:10849-10859. 10.1074/jbc.M112.446831
13. Fabbri M, Paone A, Calore F, Galli R, Gaudio E, Santhanam R, Lovat F, Fadda P, Mao C, Nuovo GJ, Zanesi N, Crawford M, Ozer GH, Wernicke D, Alder H, Caligiuri MA, Nana-Sinkam P, Perrotti D, Croce CM: MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci U S A 2012,109(31):E2110-E2116. doi: 10.1073/pnas.1209414109. Epub 2012 Jul 2 10.1073/pnas.1209414109
14. Ma L, Teruya-Feldstein J, Weinberg RA: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 1, 449:682-688. 10.1038/nature06174
15. Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, Geuze HJ: B lymphocytes secrete antigen-presenting vesicles. J Exp Med 1, 183:1161-1172. 10.1084/jem.183.3.1161
16. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY: miR-21-mediated tumor growth. Oncogene 1, 26:2799-2803. 10.1038/sj.onc.1210083
17. Sachdeva M, Zhu S, Wu F, Wu H, Walia V, Kumar S, Elble R, Watabe K, Mo YY: p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci U S A 1, 106:3207-3212. 10.1073/pnas.0808042106
18. Sachdeva M, Mo YY: MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res 1, 70:378-387. 10.1158/0008-5472.CAN-09-2021
19. Sachdeva M, Liu Q, Cao J, Lu Z, Mo YY: Negative regulation of miR-145 by C/EBP-beta through the Akt pathway in cancer cells. Nucleic Acids Res 1, 40:6683-6692. 10.1093/nar/gks324
20. Lässer C, Eldh M, Lötvall J: Isolation and characterization of RNA-containing exosomes. J Vis Exp 1, (59):e3037. doi: 10.3791/3037
21. Logozzi M, De Milito A, Lugini L, Borghi M, Calabrò L, Spada M, Perdicchio M, Marino ML, Federici C, Iessi E, Brambilla D, Venturi G, Lozupone F, Santinami M, Huber V, Maio M, Rivoltini L, Fais S: High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS One 2009,4(4):e5219. doi:10.1371/journal.pone.0005219. Epub 2009 Apr 17 10.1371/journal.pone.0005219
22. Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, Schwille P, Brugger B, Simons M: Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 1, 319:1244-1247. 10.1126/science.1153124
23. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T: Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 1, 285:17442-17452. 10.1074/jbc.M110.107821
24. Tian Y, Luo A, Cai Y, Su Q, Ding F, Chen H, Liu Z: MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J Biol Chem 1, 285:7986-7994. 10.1074/jbc.M109.062877
25. Mo MH, Chen L, Fu Y, Wang W, Fu SW: Cell-free circulating miRNA biomarkers in cancer. J Cancer Educ 2012, 3:432-448.
26. Di Leva G, Croce CM: miRNA profiling of cancer. Curr Opin Genet Dev 2013, 23:3-11.
27. Rana S, Malinowska K, Zoller M: Exosomal tumor microRNA modulates premetastatic organ cells. Neoplasia 2013, 15:281-295.
28. Yang M, Chen J, Su F, Yu B, Su F, Lin L, Liu Y, Huang JD, Song E: Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol Cancer 2011, 10:117.
29. Umezu T, Ohyashiki K, Kuroda M, Ohyashiki JH: Leukemia cell to endothelial cell communication via exosomal miRNAs. Oncogene 1, 32:2747-2755. 10.1038/onc.2012.295
30. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008,105(30):10513-10518. doi: 10.1073/pnas.0804549105. Epub 2008 Jul 28 10.1073/pnas.0804549105
31. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S, Westermann F, Speleman F, Vandesompele J, Weinberg RA: miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 2010,12(3):247-256. doi:0.1038/ncb2024. Epub 2010 Feb 21
32. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY: MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 1, 14:2348-2360. 10.1261/rna.1034808
33. Gebeshuber CA, Zatloukal K, Martinez J: miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep 1, 10:400-405. 10.1038/embor.2009.9
34. Kong W, He L, Richards EJ, Challa S, Xu CX, Permuth-Wey J, Lancaster JM, Coppola D, Sellers TA, Djeu JY, Cheng JQ: Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer. Oncogene 1, 33:679-689. 10.1038/onc.2012.636
35. Yu SJ, Hu JY, Kuang XY, Luo JM, Hou YF, Di GH, Wu J, Shen ZZ, Song HY, Shao ZM: MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer. Clin Cancer Res 1, 19:1389-1399. 10.1158/1078-0432.CCR-12-1959
36. Cai J, Guan H, Fang L, Yang Y, Zhu X, Yuan J, Wu J, Li M: MicroRNA-374a activates Wnt/beta-catenin signaling to promote breast cancer metastasis. J Clin Invest 2013, 123:566-579.
37. Axelrod R, Axelrod DE, Pienta KJ: Evolution of cooperation among tumor cells. Proc Natl Acad Sci U S A 1, 103:13474-13479. 10.1073/pnas.0606053103